大剂量甲氨蝶呤继以亚叶酸钙输注治疗头颈部癌的疗效 - Suppr

Suppr

超能文献

Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.

作者信息

Mitchell M S, Wawro N W, DeConti R C, Kaplan S R, Papac R, Bertino J R

出版信息

Cancer Res. 1968 Jun;28(6):1088-94.

PMID:4298056

Abstract

摘要

相似文献

Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.

Cancer Res. 1968 Jun;28(6):1088-94.

Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".

Cancer Res. 1970 Jun;30(6):1782-8.

Treatment of advanced cancer of head and neck by large doses of methotrexate.

J Ir Med Assoc. 1971 Jul 22;64(416):376-9.

[Antiblastic therapy, using intra-arterial infusions. Observations on 10 cases].

Boll Mal Orecch Gola Naso. 1970;88(4):261-9.

[Chemotherapy by intra-arterial path in cancer of the "head and neck" region].

Acta Chir Belg. 1971 Apr;70(4):337-50.

[Treatment of epidermoid carcinoma of the oro-pharyngo-laryngeal area with combination of methotrexate and bleomycin].

Schweiz Med Wochenschr. 1974 Jan 5;104(1):18-22.

Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease.

Cancer Res. 1965 Sep;25(8):1207-12.

Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.

JAMA. 1968 May 13;204(7):561-4.

Methotrexate in combination with radiotherapy in the treatment of squamous carcinomas of the head and neck.

Neoplasma. 1974;21(4):451-4.

Methotrexate in the treatment of squamous cell carcinomas of the head and neck.

Med J Aust. 1973 Apr 14;1(15):747-8.

引用本文的文献

Methotrexate-Induced Toxic Epidermal Necrolysis: A Rare Case Report and Review of Literature.

Indian J Crit Care Med. 2018 Oct;22(10):740-742. doi: 10.4103/ijccm.IJCCM_212_18.

The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients.

Cancer Manag Res. 2018 Oct 10;10:4471-4478. doi: 10.2147/CMAR.S172117. eCollection 2018.

Preventing and Managing Toxicities of High-Dose Methotrexate.

Oncologist. 2016 Dec;21(12):1471-1482. doi: 10.1634/theoncologist.2015-0164. Epub 2016 Aug 5.

The treatment of disseminated vasculitis with methotrexate.

Inflammation. 1976 Jun;1(3):285-95. doi: 10.1007/BF00917868.

The variability of individual tolerance to methotrexate in cancer patients.

Br J Cancer. 1971 Jun;25(2):298-305. doi: 10.1038/bjc.1971.38.

Early clinical experience with bleomycin in the United Kingdom in series of 105 patients.

Br Med J. 1972 Dec 16;4(5841):635-8. doi: 10.1136/bmj.4.5841.635.

Methotrexate and the need for continued research.

Yale J Biol Med. 1975 May;48(2):97-103.

Serum, tear and salivary concentrations of methotrexate in man.

Br J Clin Pharmacol. 1979 Feb;7(2):207-11. doi: 10.1111/j.1365-2125.1979.tb00923.x.

Effect of interaction between methotrexate and dihydrofolate reductase on DNA synthesis in L1210 cells in vitro.

Br J Cancer. 1978 Mar;37(3):403-10. doi: 10.1038/bjc.1978.60.

The protein binding of methotrexate by the serum of normal subjects.

Eur J Clin Pharmacol. 1979 Jun 12;15(5):363-6. doi: 10.1007/BF00558441.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验